A board-certified OB/GYN and Fellow of the American College of Obstetricians and Gynecologists, she completed her Bachelor of Science in Nutrition at Cornell University, her MD at Wayne State University School of Medicine, and her residency in Obstetrics and Gynecology at Albert Einstein College of Medicine
Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease
Although tirzepatide did not meet the criterion for superiority to dulaglutide with respect to the primary endpoint, a prespecified subgroup analysis suggested a possible lower incidence of death from any cause and of death from noncardiovascular causes in the tirzepatide group than in the dulaglutide group
Analytical Verification (COA) Each batch of BPC-157 / TB-500 Blend supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety